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ABSTRACT
The precursor to the Euglena light harvesting chlorophyll a/b binding protein of photosystem 11 (LHCPII) Is
a polyprotein containing multiple copies of LHCPII
covalently joined by a decapeptide linker. cDNA and
genomic clones encoding the 5 and 3' end of a 6.6 kb
LHCPII mRNA were sequenced. A 3.1 kb genomic
region encoding 1.05 kb of the 5' end of LHCPII mRNA
contains 4 introns. A 7.6 kb genomic region encoding
3.3 kb of the 3' end of LHCPII mRNA contains 10
introns. The 5' and 3' ends of the 14 Identified Euglena
introns lacked the conserved dinucleotides (5'-GT and
AG-3') found at the termini of virtually every characterized nuclear pre-mRNA intron. A common consensus splice site selection sequence could not be
identified. The Euglena introns do not have the
structural characteristics of group I and group 11 introns.
The only structural feature common to all Euglena
introns was the ability of short stretches of nucleotides
at the 5' and 3' ends of the introns to base pair, forming
a stable stem-loop with the 5' and 3' splice site
juxtaposed for splicing but displaced by 2 nucleotides.
The 26 nucleotide sequence at the 5' end of LHCPII
mRNA is absent from the genomic sequence and
identical to the 5' end of one of the small Euglena SLRNAs indicating that it is post-transcriptionally added
by trans-splicing.
INTRODUCTION
The light harvesting chlorophyll a/b binding proteins of
photosystem II (LHCPLI) are a group of abundant, highly
conserved thylakoid proteins. LHCPIIs are encoded by a nuclear
multigene family comprising approximately 3-20 members
depending upon the organism studied (1). LHCPIIs have been
classified into three types based on the amino acids found at 14
positions and the presence or absence of introns within their genes
(2). Type I LHCPIIs are encoded by intronless genes while a
single intron is present in genes encoding te II LHCPIIs. Type
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LHCPIIs can not be classified as type I or II based on amino
acid sequence and their genes often contain multiple introns.
Euglena gracilis, a unicellular protist, has a LHCPII precursor
(pLHCPII) that is a polyprotein containing multiple copies of
LHCPII covalently joined by a conserved decapeptide linker
(3-5). The amino acid sequence of Euglena pLHCPII was
deduced from the nucleotide sequence of a genomic clone (GC 18)
containing 7.4 kb of the 3' end of a LHCPII gene (4). Nine exons
were identified in this clone based on sequence homology with
Arabidopsis LHCPII. They can be assembled into a continuous
open reading frame encoding 113 amino acids of the C-terminus
of an LHCPII, followed by 4 complete LHCPIIs (4). Individual
LHCPIIs derived from this polyprotein precursor (lPEP,
1 14PEP, 351PEP 575PEP and 81 1PEP) are named relative to
their distance from the N-terminal amino acid of the encoded
polyprotein (4). The Euglena LHCPIIs are 60-70% homologous
to higher plant and green algal LHCPII and contain three
hydrophobic membrane spanning (x-helical domains as found in
other LHCPIIs (4). Maintenance of amino acid co-linearity
between Euglena and Arabidopsis LHCPII identified potential
intron-exon junctions (4) lacking the highly conserved 5'-GT
and AG-3' intron boundaries found in virtually all eukaryotic
organisms (6-8). The choice of alternative intron-exon
junctions would have resulted in major amino acid insertions or
deletions within otherwise highly homologous co-linear regions.
The Euglena nuclear gene (rbcS) encoding the ribulose1,5-bisphosphate carboxylase/oxygenase small subunit (SSU) also
lacks GT-AG intron boundaries (9), suggesting that Euglena uses
splice recognition sequences differing from those used by all other

III

organisms.
The LHCPII intron-exon junctions were identified solely
through maintenance of amino acid homology in the encoded
protein (4). Only five Euglena rbcS introns have been
characterized by direct comparison between genomic and cDNA
sequences (9). In an attempt to identify a novel consensus splice
site for Euglena nuclear pre-mRNA introns, a Euglena genomic
clone encoding the 5' half of an LHCPII polyprotein gene was
isolated. RNA-PCR was used to obtain cDNAs corresponding
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to the transcripts encoded by the Euglena LHCPII genomic
clones. Direct comparison of the genomic and cDNA sequences
identified 14 introns in the two genomic clones. These unique
introns do not contain the highly conserved GT and AG
dinucleotides present at the 5' and 3' ends, respectively, of almost
all the nuclear pre-mRNA introns characterized to date from
eukaryotic organisms as diverse as humans, plants and ciliates
(6-8). A brief report of this work has appeared (10).

MATERIALS AND METHODS
Isolation and characterization of the LHCPII genomic clone
The genomic clone, GC7, was obtained by screening a Euglena
library containing 4 x 105 recombinant phage (4). The 0.68 kb
BstXI fragment of the genomic clone GC18, encoding most of
LHCPII unit 1 14PEP (4), was used as a probe for plaque
hybridizations. The LHCPII hybridizing region of GC7 was
subcloned as a 5.2 kb (7ES52) Sall -EcoRI and a 4.8 kb (7SE48)
EcoRI-SalI fragment in pBluescript II KS (Fig. 1A). A 3.1 kb
region of the plasmid 7ES52 was further subcloned in pBluescript
II KS as a 1.6 kb PstI and an overlapping 2.0 kb Sail -Bglll
fragment (Fig. lA) for sequence analysis.
Characterization of Euglena LHCPII cDNAs
The synthesis and subcloning of NLH1, the cDNA clone
corresponding to the 5' end of Euglena LHCPII mRNA (Fig.
1A), by RNA-PCR has been described previously (11). The
cDNAs corresponding to the LHCPII transcript encoded by GC18
(Fig. 1B) were synthesized by RNA-PCR using oligonucleotide
primers corresponding to unique regions within each LHCPII
tpe encoded by GC18 (4). First strand cDNA was synthesized
from 2 ,ug of Euglena poly A+ RNA using Superscript (GIBCOBRL) reverse transcriptase as described by the supplier. The PCR
amplifications were carried out using Taq DNA polymerase
(Perkin-Elmer Cetus) for 30 cycles of 1 min at 95°C, 30 s at
56°C and 3 min (last cycle 15 min) at 720C, essentially as
described by the manufacturer. The 0.34 kb cDNA product,
LH34 (Fig. iB), was synthesized using the oligonucleotides la
(5'-CCGGAATTCTCACCGGAAAGGGCCCTGT-3') and 2a
(5'-GTGACCACCCCCAAGGCGCCCA-3'). The 1.38 kb
cDNA, LH138 (Fig. 1B), was synthesized using the
oligonucleotides la and 3b (5'-GTGGTCGACACCAGCCTGAACAAACAG-3'). The synthesis of a 0.64 kb cDNA, LH64
(Fig. 1B), utilized oligonucleotides 2b (5'-CCGTCTGCAAACAACATCTTCAGC-3' ) and 3b. For the cDNA clones, CLH22
and CLHO9 (Fig. IB), corresponding to the 3' end of the Euglena
LHCPII transcript, an anchor-(dT)17 oligonucleotide (5'-GGGAATTCGTCGACAAGCTTTTTTTTTTTTTTTTT-3') was
used for first strand synthesis. The amplification reactions
contained the anchor oligonucleotide (5'-GGGAATTCGTCGACAAGC-3') and either oligonucleotide 3a (5'-GCTGCTCACCCTGGTGCTTGAGC-3' ) for CLH22, or 2b for CLHO9
(Fig. 1B). LH34 was subcloned as a blunt-ended insert, LH138
as an EcoRP-Sail insert, LH64 as a blunt end-Sall insert, and
both CLH22 and CLHO9 as EcoRI/HindIl-blunt ended inserts
into the polylinker of pBluescript II KS.
Sequencing, Southern and Northern blots
The nucleotide sequence of all clones was determined and
analyzed as described (4). Southern and Northern blot analysis
were performed as described previously (4).

Primer extension RNA sequencing
The oligonucleotide Pex2 (5'-CTTCATGGCATCGGCGTTGTTTGGC-3') used for primer extension-RNA sequencing, was
gel purified and end labelled with 'y32P-ATP using T4
polynucleotide kinase as described (12). For sequencing, 20 ytg
of Euglena total RNA and 0.05 pmoles of labelled oligonucleotide
were heated at 90°C for 3 min in 5 yl of buffer containing 50
mM Tris-HCl, pH 8.3 and 50 mM KCl, and quickly transferred
to a waterbath for annealing at 68°C. After 10 min, reverse
transcription was carried out for 20 min at 45°C in a 20 gl
reaction volume containing 50 mM Tris-HCl, pH 8.3, 50 mM
KCl, 10 mM MgCl2, 0.5 mM spermidine, 10 mM DTT, 8 U
of AMV reverse transcriptase and 0.4 mM of each dNTP. For
sequencing, either 0.4 mM ddATP or 0.3 mM ddGTP or 0.6
mM ddTTP or 0.4 mM ddCTP was included in the appropriate
tube. Extension reactions were stopped by adding 1 1l of 0.5
M EDTA and 1 yl of DNase-free pancreatic RNase (100 itg/ml)
and incubating at 37°C for 30 min. The reaction mix was
phenol:chloroform extracted after adding 100 1l of 3M
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Figure 1. (A) Restriction map of Euglena genomic (GC7) and cDNA (NLHl)
clones encoding the 5' end of LHCPII mRNA. The Euglena insert is presented
as the boxed area while phage DNA is represented by a solid line. The arrow
indicates the direction of transcription of encoded LHCPII gene. The five exons
in the 3.1 kb sequenced segment of subclone 7ES52 are shaded. The lightly shaded
region identifies the portion of exon 1 encoding the N-terminal extension of
pLHCPII while the more heavily shaded areas indicate exon regions encoding
LHCPII unit NIPEP. Restriction sites are defined as: B-BamH, E-EcoRI,
G-BgM, H-HindM, L-Bgll, P-PstI, S-Sail, X-XhoI. Vector derived
restriction sites are in boldface. (B) RNA-PCR strategy for obtaining cDNAs
corresponding to the transcript encoded by the Euglena LHCPU genomic clone
GC18 (4). Oligonucleotides (la, 2a, 2b, 3a and 3b) specific to unique regions
of GC18 and an anchored-d(T)17 (a-d(T)17) were utilized as primers for RNAPCR. The 11 exons in GC18 are shaded. The individual LHCPII polypeptide
units encoded by the LHCPII mRNA are specified above their coding regions.
Arrows indicate the orientation of each primer. The cDNAs obtained with each
primer pair are aligned to the mRNA. All but one intron-exon junction is spanned
by at least two cDNAs.
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ammonium acetate and the products precipitated with 3 volumes
of ethanol. The pellet was dried and resuspended in 10 IA of
loading buffer (50% formamide, 10 mM EDTA, bromophenol

blue and xylene cyanol). Products were analyzed by
electrophoresis through 8% polyacrylamide sequencing gels
containing 7 M urea and visualized by autoradiography.
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Figur 2. Nucleotide sequence of the LHCPII genomic clone GC7, the LHCPII cDNA clone NLH1I (I11) and the deduced amino acid sequence of the N-terrninal
region of pLHCPII. The cDNA sequence is specified by capital letters. The amino acid sequence (single letter code) is specifiled below the first base of each codon.
A double arrow indicates the acceptor site for the 26 nucleotide splice-leader sequence that is post-transcriptionally added to LHCPII pre-mRNA by trans-splicing.
A 'TATA' box like sequence is underlined. The end of the N-terminal presequence and start of mature LHCPII is separated by a slash (/). A line above the sequence
indicates the oligonucleotide primers used for primer extension RNA sequencing (Pex2), and for the RNA-PCR synthesis (Conl and Con2) of NLH1 (11). The
GC7 sequence (nucleotides 2897-2935) absent from NLH1 which is thought to be the 3' end of exon 5 based on homology to the GC18 sequence encoding 575PEP
(4) is in italicized capital letters.
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RESULTS
A 16 kb genomic clone, GC7, containing the 5' end of a LHCPII
gene (Fig. 1A) was isolated by screening a Euglena genomic
library containing 4 x 105 recombinant phage with a fragment of
the Euglena LHCPII genomic clone, GC18, encoding LHCPII
unit 1 14PEP (4). Hybridization of strand specific in vitro
transcripts of GC7 subclones (Fig. IA) to total Euglena RNA
identified the coding strand (data not shown). The nucleotide
sequence of a 3.1 kb region of GC7, appearing to contain the
5' most end of the encoded LHCPII gene, was determined and
is presented in Figure 2 along with the derived amino acid
sequence of the encoded protein. The coding regions (exons) in
GC7 were determined by comparison with the sequence of a
cDNA clone, NLH1 (Fig. 1A), containing the 5' end of an
Euglena LHCPII mRNA (11). NLH1 was isolated by RNA-PCR
5.
N
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(11) using a 5' primer corresponding to the conserved 26 nt
added to the 5' end of all Euglena mRNAs by transsplicing (13), and two nested 3' primers (Coni and Con2, Fig.
2) corresponding to a highly conserved sequence in the C-terminal
region of Euglena LHCPII (4). The NLH1 sequence was
completely homologous to the corresponding sequence of GC7,
suggesting that it was derived from the LHCPH transcript encoded
by GC7.
The five exons identified in GC7 can be combined into an open
reading frame encoding the 33 kDa N-terminal portion of
pLHCPII consisting of a 141 amino acid N-terminal extension
(11) linked to an LHCPII unit, NIPEP (Fig. 2). The sequence
preceding the initiation codon (TTCAAAATG, Fig. 2) is
characteristic of translation initiation sites in eukaryotes (14,15),
suggesting that this is in fact the translation start site. The four
introns range in size from 86 to 436 nts while the exons range
in size from 42 to 496 nts (Fig. 2). The introns have a higher
A+T content (56%) than the exons (41 %). An analysis of codon
usage indicates a bias (64%) for codons ending with G or C as
found for other Euglena nuclear genes (4,16-18). This bias is
more pronounced in the NiPEP coding region (72%) han in the
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LHCPII units 114PEP and 575PEP (4). At the nucleic acid level,
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that of the 575PEP and 114PEP encoding exons of GC18 (4).
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encoding region of GC18 (4) suggesting that much of the nucleic
acid sequence divergence between NIPEP and 114PEP/575PEP
is the result of changes at the third position. Due to the
redundancy of the triplet code, these changes have little effect
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Flgure 3. Primer-extension RNA sequencing of the 5' end of LHCPII mRNA.
The oligonucleotide Pex2 was used to prime DNA synthesis from 20 l&g total
Eugkna RNA using AMV reverse transcriptase. Reactions were performed in
the absence of any dideoxynucleotides (0) or in the presence of the indicated
dideoxynucleotide (A, G, T or C). The sequence of the extended product
(complimentary to the mRNA sequence) is shown to the right of the sequencing
ladder. The primer-extension derived sequence of the 5' end of the LHCPII
tanscript (mRNA) and the sequence of the corresponding region of the GC7
encoded LHCPI gene (DNA) are aligned to indicate the presence of a 26 nucleodde
sequence in the message which is absent from the genomic sequence. An arrow
indicates the site of addition of this 26 nucleotide splice-leader sequence.

Figure 4. Northern blot analysis of Euglena total RNA and Southen blot analysis
of Euglena genomic DNA. (a) Total cellular RNA (20 pg) was size fractionated
on 0.8% agarose-formamide gels, transferred to nitrocellulose filters and the
filters hybridized to a 0.68 kb BstXI fragment of genomic clone GC18 encoding
LHCPII unit 114PEP (4) (Lane 1) or a 0.45 kb BamHI-BglI fragment of cDNA
clone NLHl encoding only the N-terminal extension of pLHCPII (Lane 2). (b)
Euglena DNA (10 erg) was digested to completion with EcoRI (E), BamHI (B)
or Hind[ (H), size fractionated on 0.7% agarose gels, transfred to nitrocellulose
filters and the filters hybridized to the 0.45 kb BamHI-Bgll fragment of cDNA
clone NLH1. Marker fragment sizes in kb are indicated to the right ofeach panel.
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on the protein sequence. The 3' end of NLH1 was defined by
the 3' PCR primer (Con 2, Fig. 2) used for its synthesis and
does not represent the 3' end of the last GC7 exon (exon 5). Based
on sequence homology between the 575PEP encoding region of
GC18 (4) and exon 5 of GC7, nucleotide 2935 appears to be
the 3' end of exon 5 (Fig. 2).
A single intron is found in identical positions in the regions
of Euglena genomic clone GC18 encoding LHCPII units 114PEP
and 575PEP (4). An intron is also present at the same position
(Fig. 2, nucleotides 1528-1613) in the NlPEP coding region
of GC7. The NlPEP coding region is however interrupted by
at least four additional introns (Fig. 2) not found in the
comparable coding regions of GC18 (4). The 5' and 3' ends of
the 4 introns present in the LHCPII gene encoded by GC7, as
identified by a comparison of the genomic and cDNA sequence,
do not contain the conserved GT and AG found at the ends of
virtually all eukaryotic pre-mRNA introns (Fig. 2) (6-8).
Direct primer extension RNA sequence analysis was used to
determine the sequence at the 5' end of the LHCPII mRNA
encoded by GC7 (Fig. 3). The primer extension product contained
a 26 nt sequence (5'-NNTTTCTGAGTGTCTATTTTTTTTCG-3') at the 5' end that was not present within approximately
1 kb of the GC7 sequence upstream from the translation initiation
site at nt 1063 (Fig. 2). The 5' end of the mature Euglena rbcS
mRNA contains this identical sequence which is not encoded by
the rbcS gene (13,16). This same sequence is present at the 5'
end of a group of small Euglena RNAs called spliced-leader
RNAs (SL-RNAs) and is probably added post-transcriptionally
to the 5' end of most Euglena pre-mRNAs by trans-splicing
(13,19).
A sequence comparison between the primer extension product
and GC7 identifies nt 1032 as the 5' end of the pLHCPII mRNA
encoded by GC7 (Figs. 2 and 3). A TATA box (TATATAA)
(20) is found 264 nt upstream of the 5' end of GC7 encoded
pLHCPII mRNA suggesting that the actual transcription start site
may be located approximately 240 nt upstream of this 5' end
(Fig. 2). The GC7 encoded primary transcript (pre-mRNA)
probably contains this approximately 240 nt sequence which is
removed when the 26 nt splice-leader sequence present at the
5' end of SL-RNA is addded by trans-splicing to the pre-mRNA.

RNAs of 6.6 and 9.5 kb have been identified as the LHCPII
mRNAs of Euglena (4). A 0.68 kb BstXI fragment of genomic
clone GC18 encoding most of 114PEP (4) hybridized to both
LHCPII mRNAs (Fig. 4a, lane 1). A 0.45 kb BamHI-BglI
fragment from the 5' end of cDNA clone NLH1 (Fig. IA)
encoding only the N-terminal extension region of the polyprotein
and none of the mature LHCPII (NlPEP) sequence hybridized
to only the 6.6 kb message (lane 2). The 0.45 kb BamHI-BglI
5' end probe hybridized with approximately equal intensity to
3 fragments on Euglena genomic DNA Southern blots (Fig. 4b).
A probe containing the 3' untranslated region of the GC18
encoded LHCPII gene also hybridizes only to the 6.6 kb mRNA
and to 2-3 fragments on Euglena genomic DNA Southern blots
(4). A sequence comparison of the 3' end of the 4.8 kb
EcoRI-SalI fragment (7SE48) of GC7 (Fig. IA) and the 5' end
of GC18 (4) found no overlap between the two genomic clones.
The 4.3 kb Euglena rbcS mRNA is transcribed from an
approximately 15 kb gene (9,16). The exons in GC7 and GC18
(4) comprise approximately 45% of the sequenced regions. Based
on these estimates of coding versus noncoding sequences within
Euglena genes, the combined coding capacity of the
approximately 9 kb LHCPII encoding region of GC7 and the
7.6 kb LHCPII encoding region of GC18 (4) is 5.0-7.4 kb. It
can not be determined whether GC7 and GC18 are the 5' and
3' ends of the same gene or whether they represent different
members of the 3 gene family encoding the 6.6 kb LHCPII
message.

The previously characterized genomic clone GC18 encodes the
C-terminal half of a Euglena LHCPII polyprotein (4). Based on
the criteria of maintaining maximum amino acid sequence
homology between Euglena and Arabidopsis LHCPII, 8 introns
were tentatively identified (4). None of the 8 introns contained
the universally conserved GT -AG intron borders (4). Euglena
LHCPII could however contain numerous aminoacid insertions
and deletions resulting in the misidentification of intron-exon
junctions. A comparison of cDNA and genomic sequences was
performed to identify the true intron-exon junctions of GC18
and thus demonstrate the uniqueness of the intron borders in the
Euglena LHCPII gene. GC18 encodes 3 types of LHCPIIs having
more than 90% nucleotide sequence homology within a type (4).
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Figure 5. Nucleotide sequence of the 3' end of the LHCPII polyprotein genomic clone GC18 (4), the LHCPII cDNA clones CLHO9 and CLH22, and the deduced
amino acid sequence of the C-terminal region of pLHCPII. The cDNA sequence is specified by capital letters. The amino acid sequence (single letter code) is specified
below the first base of each codon. An asterisk (*) indicates the stop codon. The sequence begins at the 5' end of the ninth exon (Ex9) of the previously published
GC18 encoded LHCPII gene (4) and extends beyond the 3' end of the LHCPII mRNA. The Sall site marking the end of the previously published GC18 sequence
(4) is underlined. A double arrow indicates the G at nucleotide 7258 that is absent from the published GC18 sequence (4).
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Oligonucleotides specific to unique coding sequences witiin each
LHCPII tpe were used for cDNA synthesis and PCR
amplification (Fig. 1B). Due to the presence of more than one
unit of each LHCPII tpe within a given polyprotein gene, each
oligonucleotide could potentially prime DNA synthesis at more
than one site. The oligonucleotide pairs for RNA-PCR were
therefore chosen so that a single product of known size spanning
one or more introns would be produced based on the known linear
order of LHCPII types within the characterized region of GC18
(Fig. iB). Priming within other regions of the mRNA would
produce either no product or products differing in size from the
desired cDNA.
Five overlapping cDNAs (LH34, LH64, LH138, CLHO9 and
CLH22), completely spanning the coding region of GC18, were
obtained and sequenced (Fig. iB). All but one (spanning 3In6,
the only intron in 575PEP) of the intron-exon junctions were
identified by comparing the genomic sequence to the sequence
of two or more cDNA clones synthesized using different primer
pairs. The sequence of these cDNA clones is completely
homologous to the exon sequences from GC18 (data not shown)
confirming that they were derived from mRNA transcribed from
this gene. Alignment of the cDNA and GC18 sequences identified
10 introns (Figs 5 and 6). Eight introns (3In -3In8)
corresponded to those previously identified by the criteria of
preservation of coding sequence (4). Two previously unidentified
introns (31n9, 31nlO) were identified at the 3' end of GC18 (Figs
5 and 6). All introns lacked the GT-AG border sequences found
in all other eukaryotes (Fig. 6). The intron-exon junctions of
3In3 and 3In5 differ from those previously reported (4) based
on the criteria of conserved amino acid sequence. The actual
intron-exon junction of 31n3 inserts an alanine at amino acid
25 (nucleotides 1653-1655 of GC18 sequence) of 35 1PEP. The
actual intron-exon junction of 3In5 changes amino acid 95 of
351 PEP from alanine to threonine. The GenBank sequence
(accession number X61361) has been updated to reflect the
correct intron-exon junctions and complete the 3' end sequence
of the encoded LHCPII gene.
cDNAs CLHO9 and CLH22 (Fig. 1B) contain the 3' end of
the GC18 encoded transcript. Comparison between the cDNAs
and GC18 sequence (4) identified a single nucleotide difference
between the two sequences in this region. The cDNA contained
a G that was not found during the initial sequencing of GC18
(4). This region of GC18 was resequenced and the G present
in the cDNA was found in GC18. The sequence of the 3' end
of GC18 revised by insertion of a G at nucleotide 7258 and the
corresponding cDNA sequence are presented in Figure 5. The
previously published GC18 sequence (4) ended at the SalI site.
A comparison of the genomic and cDNA sequences identified
two additional introns, 3In9 and 3HnMO, at the 3' end of GC18
(Figs. 5 and 6). The region downstream of the Sall site contains
the last exon (Ex 1l) of the polyprotein gene (Fig. 5). The GC18
encoded LHCPII mRNA contains a 109 nucleotide non-translated
3' end (Fig. 5). The penultimate exon (ExlO) encodes the Cterminus of the LHCPII polyprotein and LHCPII unit 81 iPEP
(4), as well as the first 22 nt of the 3' non-translated end of
LHCPII mRNA (Fig. 5). The high degree of nucleic acid
sequence homology between the 811PEP and IPEP coding
regions (97%) (4) extends to the presence of introns (31nl and
31n9) at the same position within both coding regions and seven
identical nucleotides at the 5' end of the introns (Fig. 6). This
high degree of sequence homology is not found at the 3' end
of the introns (Figs. 5 and 6). The last exon (Exl 1) encodes most

of the 3' non-translated end of the LHCPII mRNA (Fig. 5). A
polyadenylation signal (AATAAA) found 11-30 nt upstream
of the site of poly (A) addition in many but by no means all
eukaryotic nuclear transcripts (20) was not found in the 3' nontranslated region.
The 10 GC18 and 4 GC7 intron-exon junction sequences are
presented in Figure 6 with the consensus nucleotides witiin the
intron shaded for ease of comparison. Except for introns 3In9
and 5In4, the presence of identical nucleotides at the 5' and 3'
intron-exon junctions make splice site selections ambiguous.
Splice sites were chosen to maxiiize homology witiin the 5'
end of the intron. Of the 14 introns in the LHCPII gene, only
two contain the 5' GT and none contain the 3' AG (Fig. 6) found
at the 5' and 3' ends, respectively, of virtually every nuclear premRNA intron (6- 8). A common sequence was not apparent at
the 5' or 3' intron-exon junction even in the case of the two
intron pairs (5Inl and 3In2, 3In1 and 3In9) that are at identical
positions within highly conserved coding regions (Fig 6).
The sequence alignment identifies a number of positions with
nonrandom nucleotide usage. All introns contain a purine (A or
G) at the 5' end and all but one, 3In9, contain a pyrimidine (C
or T) at the 3' end (Fig. 6). All exons contain a purine at the
5' end and all but one, Ex5, contain a pyrimidine at the 3' end
(Fig. 6). One other highly conserved intron feature is a CA at
nt positions 4 and 5 from the 5' end of 11 introns and a
complementary TG at nt positions 7 and 6 from the 3' end of
10 introns (Fig. 6). This complementary CA, TG pair is replaced
by a complementary AG, CT pair in intron 3In1O and a
complementary CT, AG pair in intron 3In3. The two remaining
introns, 5Inl and 3In4, contain respectively a CA, GG and TG,
CC pair where only one of the two nucleotides are
complementary. Three of the five sequenced Euglena rbcS
introns, i2 (CA, TG), ile (AG, TT) and i3e (GG, CC), have
complementary dinucleotide pairs at nt positions 4 and 5 from
the 5' end and at nt positions 7 and 6 from the 3' end of the
intron (9). Although the sample set is small, the lack of a
consensus splice site is apparent and implies that structural rather
than sequence information is used for splice site selection in
Euglena.
The Euglena LHCPII introns could not be folded into the highly
conserved secondary structures characteristic of group I (21) and
3
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Figure 6. Alignment of the 14 intron-exon junctions in the Euglena LHCPII
genomic clones GC7 and GC18 (4). Intron-exon junctions were identified by
comparing the cDNA and genomic sequences. The introns in Eugena genomic
clone GC7 encoding the 5' end of LHCPII mRNA are labelled as SInI -4; 51n1
being the 5' most intron. The introns in Euglena genomic clone GC18 (4) encoding
the 3' end of LHCPII mRNA are labelled as 3Inl-10; 31n1 being the 5' most
intron. In a number of cases, splice site identification is ambiguous due to sequence
duplication at the intron exon junctions. Splice sites were chosen and sequences
aligned to obtain maximum nt sequence homology at the 5' end of the intron.
A consensus sequence for the 5' and 3' intron ends was determined and the
consensus nucleotides within the intron are shaded for ease of comparison.
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group 1 (22) introns. The introns in the Euglena rbcS gene fold
into stem-loop structures with the splice sites juxtaposed but offset
by 1 or 2 nt (9). Complementarity between short stretches of
nucleotides within the 5' and 3' ends of all the sequenced Euglena
LHCPII introns allowed the introns to be folded into similar stemloop structure with the 5' and 3' splice sites juxtaposed but offset
by 2 nt, except for intron 51nl where the offset is 3 nt. Inspection
of the intron 5' and 3' ends forming the stem loop structures
(Fig. 6) shows that except for the conserved complementary CA and TG dinucleotides, the distribution of base pairs within the
stem varied from intron to intron. The positional variation in the
base paired nucleotides explains the lack of a conserved sequence
at the 5' and 3' ends of the intron. The 'fold' and 'mfold'
programs of the GCG sequence analysis package (23) failed to
reveal more complex shared structural features among the
Euglena introns. Most RNA regions can be folded into stable
stem loop structures. Whether base pairing between the 5' and
3' end of the intron is required for splicing of these unique class
of introns remains to be seen.

DISCUSSION
The Euglena LHCPII gene encodes a polyprotein composed of
multiple copies of at least three types of LHCPII (4). Within a
type, there is over 90% nucleotide and amino acid sequence
conservation while between types, there is approximately
60-70% sequence homology; the same amount of homology
found between Euglena LHCPII and higher plant LHCPII (4).
The conservation of coding sequences is in marked contrast to
the divergence of intron position and sequence. The GC7 region
encoding NlPEP is 87% homologous to the GC18 regions
encoding 114PEP and 575PEP (4). GC7 and GC18 either encode
portions of two different LHCPII genes or if they are portions
of the same gene, the NIPEP coding region is approximately
6-8 kb 5' to the 114PEP coding region. The NIPEP coding
region contains at least 5 introns while the 114PEP and 575PEP
coding regions (4) contain a single intron in the same position
as the first of the 5 introns within the NIPEP coding region. The
respective introns exhibit less than 40% sequence identity even
though the flanking exons are greater than 90% homologous. The
maintenance of a high degree of sequence homology among
physically dispersed exons suggests selection pressure on the exon
encoded domains. Higher plants also contain multiple LHCPII
(1,2) types but it remains to be established whether they are
functionally different. Functional differences among the multiple
LHCPIIs found in all chlorophyll a/b containing organisms would
provide the selection pressure needed to maintain sequence
homology among physically dispersed exons encoding different
LHCPII types.
Sequence comparisons between the genomic and cDNA clones
revealed that Euglena LHCPII pre-mRNA processing requires
both cis- and trans-splicing. The 5' end of LHCPII mRNA
contains a 26 nt sequence that is not encoded by the immediately
upstream genomic sequence. This sequence is identical to the
non gene encoded 26 nt sequence found at the 5' end of rbcS
mRNA (13) and is also identical to the 26 nt sequence at the
5' end of cytoplasmic EF-lc mRNA (24) and chloroplast IF-3
mRNA (25). This 26 nt sequence appears to be trans-spliced from
the 5' end of one of the Euglena SL-RNAs (13,19) to the
pre-mRNA.
Trypanosomes and nematodes are the only other organisms
known to form the 5' end of their mRNAs by trans-splicing (26).

Trans-splicing occurs in trypanosomes and nematodes with
removal of an intron and formation of the 5' end of the mRNA
by transfer of a leader sequence from a small SL-RNA, to the
pre-mRNA (26-29). Euglenoids are phylogenetically related to
trypanosomes (30-32). Trypanosome SL-RNAs contain a
UUG/GUA exon/intron boundary (29.33.34) while Euglena SLRNAs contains a UCG/GUA exon/intron boundary (13,19).
Similarities between trans-splicing in Euglena, trypanosomes
(26,29), and nematodes (27,28) such as an AG dinucleotide at
the 3' splice acceptor site and removal of an intron (approximately
240 nts in case of Euglena LHCPII) from the pre-mRNA during
trans-splicing suggest that the mechanism of trans-splicing in
Euglena is similar to that used by both trypanosomes and
nematodes.
Nuclear pre-mRNA cis-splicing appears to be an evolutionarily
conserved process that has been most extensively characterized
in yeast and mammals (6,35). The yeast and mammalian splicing
complex, the spliceosome, is composed of the pre-mRNA, five
small nuclear RNAs (snRNAs) and a large number of proteins
(6,35). Virtually all eukaryotic pre-mRNA introns contain
invariant 5'-GT and AG-3' borders (6-8). In addition to the
invariant GT -AG borders, yeast introns contain a G 5
nucleotides downstream from the 5' splice site and a consensus
branch point sequence about 30-40 nucleotides from the 3' splice
site (35) while many mammalian introns contain a polypyrimidine
tract at the 3' end of the intron (6,7). Splice site selection in both
yeast and mammals involves interactions between the snRNAs
and conserved sequences at both the splice site and within the
intron (36-39). A non-Watson-Crick interaction between the
terminal guanosines of the invariant GT-AG pair appears to be
essential for positioning the 3' splice site for cleavage and exon
ligation (40). The fourteen Euglena LHCPII mRNA introns and
five Euglena rbcS mRNA introns (9) lacked GT -AG borders
and there were no identifiable conserved intron sequences as
found in cis-spliced nuclear pre-mRNA introns of other
eukaryotes. This suggests that cis-splicing in Euglena is
fiundamentally different from the well characterized evolutionarily
conserved spliceosome system of other eukaryotes.
The complete sequencing of the Euglena chloroplast genome
has identified a large number of introns which include at least
74 group 11 introns, 64 group III introns and 15 twintrons, the
introns within introns (41,42). The LHCPII introns and rbcS
introns (9) could have evolved prior to transfer of the respective
gene from the chloroplast to the nucleus during the reduction
of a photosynthetic endosymbiont to a chloroplast. Group II
introns are identified by conserved sequence elements and
conserved secondary structures (22,42). Group III introns have
fewer conserved features but they appear to be characterized by
a group II intron-like domain VI at their 3' end (42-44).
Secondary structures or conserved sequence elements
characteristic of group II or group HI introns could not be
identified in the LHCPII introns. The only structural feature
common to the Euglena LHCPII and rbcS introns (9) is the
formation by hydrogen bonding of a stem between the 5' and
3' ends of the intron leaving the splice site juxtaposed but offset
by 1-3 nt. Although the sample set is restricted to LHCPII and
rbcS (9) pre-mRNA introns, Euglena nuclear encoded pre-mRNA
introns appear to represent an entirely new, hitherto uncharacterized intron type.
Morphological criteria (30), cytoplasmic rRNA sequence
comparisons (31) and trans-splicing of nuclear pre-mRNAto
(13,26) indicate that euglenoids are most closely related
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trypanosomes. The Euglenoid-trypanosome lineage is thought to
be the most ancient protistan lineage having diverged prior to
separation of all other protistans (32). Cis-spliced introns are
absent from trypanosome genes (45), suggesting that the
spliceosome dependent cis-splicing system found in most
organisms evolved after their separation from the Euglenoidtrypanosome lineage. The ancestral Euglenoid is generally
accepted to have been a phagotrophic trypanosome like organism
that engulfed a eukaryotic algae (46,47). The transfer of intron
containing chloroplast genes from the endosymbiotic algae to the
nucleus of the trypanosome like host during reduction of the
endosymbiont to a chloroplast would have required development
of a cis-splicing system. The independent evolution of Euglena
cis-splicing would explain the absence of conserved GT-AG
intron borders and suggests that fundamental differences exist
between the well characterized spliceosome cis-splicing system
found in most organisms and the as yet uncharacterized cissplicing system of Euglena.
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